|
Multiple sclerosis
Citations 251-260 of 469 total displayed.
|
Past content
(since Jan 2001):
|
- BRIEF COMMUNICATIONS
Polyneuropathy associated with interferon beta treatment in patients with multiple sclerosis
- Dana Ekstein, Eduard Linetsky, Oded Abramsky, and Dimitrios Karussis
Neurology 2005; 65: 456-458.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Vagal nerve stimulation effects on cerebellar tremor in multiple sclerosis
- F. Marrosu, A. Maleci, E. Cocco, M. Puligheddu, and M. G. Marrosu
Neurology 2005; 65: 490.
[Full text]
[PDF]
- ARTICLES
Brain atrophy and lesion load in a large population of patients with multiple sclerosis
- G. Tedeschi, L. Lavorgna, P. Russo, A. Prinster, D. Dinacci, G. Savettieri, A. Quattrone, P. Livrea, C. Messina, A. Reggio, V. Bresciamorra, G. Orefice, M. Paciello, A. Brunetti, G. Coniglio, S. Bonavita, A. Di Costanzo, A. Bellacosa, P. Valentino, M. Quarantelli, F. Patti, G. Salemi, E. Cammarata, I. L. Simone, M. Salvatore, V. Bonavita, and B. Alfano
Neurology 2005; 65: 280-285.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Neutralizing anti-IFN-ß antibodies: How much more evidence do we need to use them in practice?
- Gavin Giovannoni and Andrew Goodman
Neurology 2005; 65: 6-8.
[Full text]
[PDF]
- ARTICLES
Appearance and disappearance of neutralizing antibodies during interferon-beta therapy
- P. Soelberg Sorensen, N. Koch-Henriksen, C. Ross, K. M. Clemmesen, K. Bendtzen, and the Danish Multiple Sclerosis Study Group
Neurology 2005; 65: 33-39.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Neutralizing antibodies and efficacy of interferon ß-1a: A 4-year controlled study
- L. Kappos, M. Clanet, M. Sandberg-Wollheim, E. W. Radue, H. P. Hartung, R. Hohlfeld, J. Xu, D. Bennett, A. Sandrock, S. Goelz, and the European Interferon Beta-1a IM Dose-Comparison Study Investigators
Neurology 2005; 65: 40-47.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Interferon ß-1a in MS: Results following development of neutralizing antibodies in PRISMS
- Gordon S. Francis, George P.A. Rice, Jonathan C. Alsop for the PRISMS (Prevention of Relapses and Disability by Interferon ß-1a Subcutaneously in Multiple Sclerosis) Study Group
Neurology 2005; 65: 48-55.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients
- A. Minneboo, B. M. J. Uitdehaag, H. J. Ader, F. Barkhof, C. H. Polman, and J. A. Castelijns
Neurology 2005; 65: 56-61.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
High sensitivity measurement of CRP and disease progression in multiple sclerosis
- M. Soilu-Hänninen, J. O. Koskinen, M. Laaksonen, A. Hänninen, E. -M. Lilius, and M. Waris
Neurology 2005; 65: 153-155.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Life-threatening acute pancreatitis associated with interferon beta-1a treatment in multiple sclerosis
- Rune Midgard, Kåre Ertresv Åg, Erik Trondsen, and Olav Spigset
Neurology 2005; 65: 170-a-171-a.
[Full text]
[PDF]
|
|
